Quantitative Brokers Launches Futures Execution Algorithm

New algorithm, Closer, targets best execution around closing price benchmarks for market-on-close and target close futures orders.

new-york-city-skyline
Quantitative Brokers is headquartered in New York.

The Closer algo utilizes real-time analytics to automatically determine optimal start and end times for market-on-close (MOC) or "Target Close" futures orders via existing EMSsand OMSs. Closer orders are integrated into QB's Transaction Cost Analytics (TCA) platform, providing transparency into every child order and action taken by the algorithm.

Closer is the fifth in QB's suite, alongside the Bolt, Strobe, Legger and The Roll algorithms.

"Algorithmic trading is rapidly gaining traction across the capital markets, especially as firms are becoming more aware of how important best execution practices are to their business," said Christian Hauff, CEO of Quantitative Brokers, in a statement.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Removal of Chevron spells t-r-o-u-b-l-e for the C-A-T

Citadel Securities and the American Securities Association are suing the SEC to limit the Consolidated Audit Trail, and their case may be aided by the removal of a key piece of the agency’s legislative power earlier this year.

Enough with the ‘Bloomberg Killers’ already

Waters Wrap: Anthony interviews LSEG’s Dean Berry about the Workspace platform, and provides his own thoughts on how that platform and the Terminal have been portrayed over the last few months.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here